 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
* g( c! }$ i* F3 O0 R4 _* ?* _ ' T7 t, n: V( ^$ E; B
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
& p# U& q# Y$ O' } * ?: Z& K6 l6 R& b) Y$ D# H
BY THE EDMONTON JOURNAL FEBRUARY 16, 2007/ M* H* e: k% G& @8 n) f; z
# X2 k0 ]' S$ r, F s$ ?' S
+ e- v& d) S# @" S3 z
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
% H) D/ `% K8 K$ r) L/ j
" i! G8 `" s/ ^7 qThe agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
, b" p4 C% b) g. Z
* Z8 { Q& N: c! x" }/ WThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.# i* g. Y7 M- i) o
1 u- V' U' k( P$ m! O9 nIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.# o) S! j' S7 q$ O0 S
& A) |+ _& b7 j% v" A5 w( c4 H8 cIt certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.% S- Z5 L8 F9 G# _3 ~! U8 ?7 Y5 Q, K2 b
( w" u, \- R8 F8 r% S3 w"As a scientist, it's one of the highlights of my CAREER," Shan said.
2 H2 C4 Y7 g1 \; Y: h3 Z2 c
% V; Y4 D! v+ ?% z; ^7 i2 a1 A"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
+ u# g% f/ F9 E6 V" R. \8 f3 l
5 X. D0 J6 f8 U6 m: z9 l( {$ rIt's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
+ ^2 P% B5 ?) @) X! D: Q9 D
9 J, W7 B! q( U' j4 f1 v9 yGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.1 [4 B3 g# Z6 L& n# b
% a- Y+ G8 e: q* \The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.( d z ~7 ]* b- G, w2 f8 d
4 V! o) I! }& U M) C4 d8 F
8 Y! F, T1 y4 h/ D& H; G% L% Nhttp://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
9 `/ m, A/ Y6 V& F! H c% V
发表于 2015-2-28 19:45
